1. |
潘长玉,高妍,袁申元,等.2型糖尿病下肢血管病变发生率及相关因素调查[J].中国糖尿病杂志, 2001, 9(6):323-326.
|
2. |
徐新华,胡家美,唐尚权.下肢动脉硬化闭塞症患者预后影响因素[J].中国老年学杂志, 2013, 33(13):3241-3242.
|
3. |
郑子恢.安步乐克[J].中国新药杂志, 1999, 8(11):772-773.
|
4. |
任师颜,王非,钱松屹,等.盐酸沙格雷酯治疗下肢动脉硬化闭塞症的疗效观察[J].中日友好医院学报, 2012, 26(3):142-144.
|
5. |
中华医学会糖尿病学分会.中国2型糖尿病防治指南(2010年版)[J].中国糖尿病杂志, 2012, 20(1):S1-S37.
|
6. |
Komai H, Obitsu Y, Shigematsu H.Diabetes and old age could affect long-term patency of paramalleolar distal by-pass for peripheral arterial disease in Japanese patients[J].Circ J, 2011, 75(10):2460-2464.
|
7. |
莫爵飞,闫秀峰,倪青.芪蛭降糖胶囊治疗2型糖尿病早期下肢动脉硬化闭塞症104例[J].环球中医药, 2013, 6(2):105-110.
|
8. |
黄琼刁,邓万溪,黄钦展,等.糖尿病主要并发症年龄与体质之相关性研究[J].世界中医药, 2013, 8(3):288-290.
|
9. |
萧剑彬,林少芒,张智辉,等.多层螺旋CT血管成像技术对糖尿病下肢动脉硬化闭塞症的临床诊断价值[J].中国医学工程, 2014, 22(3):1-3, 6.
|
10. |
Saxon RR, Coffman JM, Gooding JM, et al.Long-term patency and clinical outcome of the Viabahn stent-graft for femoropopliteal artery obstructions[J].J Vasc Interv Radiol, 2007, 18(11):1341-1349.
|
11. |
Rutherford RB.Clinical staging of acute limb ischemia as the basis for choice of revascularization method:when and how to intervene[J].Semin Vasc Surg, 2009, 22(1):5-9.
|
12. |
杨韵宏.血管内皮功能与2型糖尿病下肢血管病变关系探讨[J].实用临床医药杂志, 2012, 16(7):107-109.
|
13. |
高伟,王芳,刘关键,等.盐酸沙格雷酯治疗周围动脉疾病疗效与安全性的系统评价[J].中国循证医学杂志, 2012, 12(3):341-346.
|
14. |
时德.5-HT2受体拮抗剂在外周动脉疾病治疗中的地位[J].中国处方药, 2012, 10(3):16-19.
|
15. |
Origuchi N, Shigematsu H, Muto T.Anplag, a selective 5-HT2 receptor antagonist, reduces stenosis induced by balloon injury in the hypercholesterolaemic rabbit[J].Int Angiol, 1997, 16(3):204-209.
|